E-Lessons

Brexpiprazole (Rexulti®)

The United States Food and Drug Administration (FDA) approved   brexpiprazole (brand name “Rexulti®”) in July 2015 for two indications:   the treatment of schizophrenia and as adjunctive therapy to antidepressants for the treatment of major depressive disorder (MDD). Rexulti® is manufactured by Otsuka Pharmaceutical Company Ltd and co-marketed with […]

Asenapine (Saphris®)

Asenapine (US brand name Saphris®) is a second-generation (“atypical”) antipsychotic. FDA-approved indications 1. Schizophrenia 2. Acute treatment of manic and mixed episodes associated with bipolar I disorder (monotherapy) 3. Acute treatment of manic and mixed episodes associated with bipolar I disorder (adjunctive to lithium or valproate) […]

Aripiprazole (Abilify®)

Aripiprazole (US brand name Abilify® and generic Aripiprix, zolonda) is a second-or third generation (atypical) antipsychotic. FDA-approved indications A. Oral 1. Schizophrenia 2. Acute treatment of manic and mixed episodes associated with bipolar I disorder 3. Adjunctive treatment of major depressive disorder 4. Irritability associated with […]

Haloperidol

Haloperidol (US brand name Haldol® and generic) is a first-generation (“typical”) antipsychotic. Here is basic information about this medication. Oral Haloperidol (Tablets, Oral concentrate) FDA-approved indications 1. Management of manifestations of psychotic disorders 2. Control of tics and vocal utterances of Tourette’s Disorder in children and adults 3. […]

Learning inforgraphs

Find more education infographics on e-Learning Infographics Find more education infographics on e-Learning Infographics Find more education infographics on e-Learning Infographics Find more education infographics on e-Learning Infographics Find more education infographics on e-Learning Infographics Find more education infographics on e-Learning Infographics

Subdivision of depression

Depression : What is not?